Skip to content

Homeopathic medicines for patients with plugged nose, runny nose, sneezing, coryza, cough, scratchy throat, sore throat, pharyngeal redness

Efficacy of individualized homoeopathic medicines in the treatment of upper respiratory tract infection in adolescents and adults: A double-blind, randomized, placebo-controlled trial - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/093341
Enrollment
192
Registered
2025-08-20
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J06- Acute upper respiratory infectionsof multiple and unspecified sites

Interventions

Intervention1: Individualized Homoeopathic Medicines with Concomitant care: Intervention is planned as administering the indicated homeopathic medicine in the desired dosage in centesimal potency as p

Sponsors

D N De Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Adolescent age group (10 to 19 years) and Adult (19 to 60) age group 2) Either sex group or transgender 3) Clinical signs and symptoms of an URTI with a duration of greater than 24 hours with or without a fever greater than 37.5 degrees Celsius (axillary body temperature). 4) At least 1 of 3 types of URTI symptoms?nasal (plugged nose, runny nose, sneezing), pharyngeal (scratchy throat, sore throat, pharyngeal hyperaemia), and cough (ordinary cough without suspicion of acute lower respiratory tract disease) 5) At least 1 of 5 general symptoms?feeling tired, weakness, body ache, irritable or whining, or less active

Exclusion criteria

Exclusion criteria: 1) Not providing written assent or consent of participation. 2) Progress to lower respiratory tract infection and Severe or complicated course of URTI?e.g., bronchitis, pneumonia etc. 3) Severe concomitant diseases (renal failure, heart anomalies, circulatory failure, cardiomyopathy, decompensated kidney and liver, immunosuppressive conditions, and oncological diseases). 4) Known or suspected hypersensitivity to any component of the study medication 5) Use of immunomodulatory medications. 6) Being vaccinated against influenza within the last 6 months before the start of the study. 7) Vulnerable population?unconscious, non-ambulatory, too sick for consultation, differently abled, or terminally or critically ill. 8) Subjects undergoing homeopathic treatment for any chronic disease(s) within last 15 days 9) Simultaneous participation in any other clinical trial. 10) History of atopy & allergy 11) Fever more than 105 degree F 12) Oxygen saturation level below 90 percent

Design outcomes

Primary

MeasureTime frame
Time (Day) to complete resolution of symptoms of URTI.Timepoint: 15 days of intervention

Secondary

MeasureTime frame
Canadian Acute Respiratory Illness and Flu Scale (CARIFS)Timepoint: Baseline and at days 1, 2, 3, 5, 7, 10, and 15 of intervention.;Wisconsin Upper Respiratory Symptom Survey (WURSS-21)Timepoint: Baseline and at days 1, 2, 3, 5, 7, 10, and 15 of intervention.;Complete blood count (CBC)Timepoint: At baseline and after 15 days of intervention.

Countries

India

Contacts

Public ContactSanjib Sarkar

D N De Homoeopathic Medical College and Hospital

dr.aradhanagupta95@gmail.com7449886701

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026